论文部分内容阅读
为评价以静脉内给予大剂量白介素２为基础的免疫方法在治疗肾脏未切除的肾细胞癌转移灶中的疗效，作者回顾性分析了自１９８６～１９９６年间的６０７例曾接受过ＩＬ２治疗的肾癌患者，这些患者均有肾外转移灶，且免疫治疗均在冲洗膀胱５～７次后行γ照相显像。对肿瘤局部
To evaluate the intravenous administration of high-dose interleukin 2-based immunotherapy in the treatment of unresectable renal cell carcinoma metastases in the efficacy of the author retrospectively analyzed from 1986 to 1996, 607 cases had received IL 2 Treatment of patients with renal cell carcinoma, these patients have extra-renal metastases, and immunotherapy were washed in the bladder 5 to 7 times after the gamma camera. On the tumor part